Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic
  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Global Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027 - ResearchAndMarkets.com

The "Adult Hemoglobinopathy Testing: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Adult Hemoglobinopathy Testing Market to Reach $447.8 Million by 2027

In the changed post COVID-19 business landscape, the global market for Adult Hemoglobinopathy Testing estimated at US$343.8 Million in the year 2020, is projected to reach a revised size of US$447.8 Million by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. HPLC Test, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$276.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $93 Million, While China is Forecast to Grow at 6.2% CAGR

The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$93 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$89.5 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$58.8 Million by the year 2027.

Hb Electrophoresis Segment to Record 4.8% CAGR

In the global Hb Electrophoresis segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39 Million in the year 2020 will reach a projected size of US$53.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.2% CAGR through the analysis period.

Select Competitors (Total 44 Featured) -

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

For more information about this report visit https://www.researchandmarkets.com/r/5arxhm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.